Acute Morphine, Chronic Morphine, and Morphine Withdrawal Differently Affect Pleiotrophin, Midkine, and Receptor Protein Tyrosine Phosphatase β/ζ Regulation in the Ventral Tegmental Area

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2016 Jan 9

PMID 26742526

Citations 6

Authors

Daniel Garcia-Perez

M Luisa Laorden

M Victoria Milanes

Affiliations

Soon will be listed here.

Abstract

Pleiotrophin (PTN) and midkine (MK) are secreted growth factors and cytokines, proposed to be significant neuromodulators with multiple neuronal functions. PTN and MK are generally related with cell proliferation, growth, and differentiation by acting through different receptors. PTN or MK, signaling through receptor protein tyrosine phosphatase β/ζ (RPTPβ/ζ), lead to the activation of extracellular signal-regulated kinases (ERKs) and thymoma viral proto-oncogene (Akt), which induce morphological changes and modulate addictive behaviors. Besides, there is increasing evidence that during the development of drug addiction, astrocytes contribute to the synaptic plasticity by synthesizing and releasing substances such as cytokines. In the present work, we studied the effect of acute morphine, chronic morphine, and morphine withdrawal on PTN, MK, and RPTPβ/ζ expression and on their signaling pathways in the ventral tegmental area (VTA). Present results indicated that PTN, MK, and RPTPβ/ζ levels increased after acute morphine injection, returned to basal levels during chronic opioid treatment, and were upregulated again during morphine withdrawal. We also observed an activation of astrocytes after acute morphine injection and during opiate dependence and withdrawal. In addition, immunofluorescence analysis revealed that PTN, but not MK, was overexpressed in astrocytes and that dopaminergic neurons expressed RPTPβ/ζ. Interestingly, p-ERK 1/2 levels during chronic morphine and morphine withdrawal correlated RPTPβ/ζ expression. All these observations suggest that the neuroprotective and behavioral adaptations that occur during opiate addiction could be, at least partly, mediated by these cytokines.

Citing Articles

Targeting the cytoskeleton as a therapeutic approach to substance use disorders.

Pandey S, Miller C Pharmacol Res. 2024; 202:107143.

PMID: 38499081 PMC: 11034636. DOI: 10.1016/j.phrs.2024.107143.

Psilocin suppresses methamphetamine-induced hyperlocomotion and acquisition of conditioned place preference via D2R-mediated ERK signaling.

Wang J, Liang M, Shang Q, Qian H, An R, Liu H CNS Neurosci Ther. 2023; 29(3):831-841.

PMID: 36627756 PMC: 9928547. DOI: 10.1111/cns.14054.

Prefrontal Cortex Response to Prenatal Insult and Postnatal Opioid Exposure.

Rymut H, Rund L, Southey B, Johnson R, Sweedler J, Rodriguez-Zas S Genes (Basel). 2022; 13(8).

PMID: 36011282 PMC: 9407090. DOI: 10.3390/genes13081371.

Neuronal apoptosis induced by morphine withdrawal is mediated by the p75 neurotrophin receptor.

Asuni G, Speidell A, Mocchetti I J Neurochem. 2021; 158(2):169-181.

PMID: 33742683 PMC: 10176599. DOI: 10.1111/jnc.15355.

Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Parekh S, Paniccia J, Lebonville C, Lysle D Psychopharmacology (Berl). 2020; 237(12):3653-3664.

PMID: 32860071 PMC: 7686097. DOI: 10.1007/s00213-020-05645-2.

References

Guitart X, Nestler E . Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J Neurochem. 1993; 61(5):1766-73. DOI: 10.1111/j.1471-4159.1993.tb09814.x. View

Kim Y, Ryu J, Lee H, Lim I, Park D, Lee M . Midkine, heparin-binding growth factor, blocks kainic acid-induced seizure and neuronal cell death in mouse hippocampus. BMC Neurosci. 2010; 11:42. PMC: 2861065. DOI: 10.1186/1471-2202-11-42. View

Herradon G, Perez-Garcia C . Targeting midkine and pleiotrophin signalling pathways in addiction and neurodegenerative disorders: recent progress and perspectives. Br J Pharmacol. 2013; 171(4):837-48. PMC: 3925022. DOI: 10.1111/bph.12312. View

Ridet J, Malhotra S, Privat A, Gage F . Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1998; 20(12):570-7. DOI: 10.1016/s0166-2236(97)01139-9. View

Mailleux P, Preudhomme X, Albala N, Vanderwinden J, Vanderhaeghen J . delta-9-Tetrahydrocannabinol regulates gene expression of the growth factor pleiotrophin in the forebrain. Neurosci Lett. 1994; 175(1-2):25-7. DOI: 10.1016/0304-3940(94)91069-3. View

Ikemoto S . Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev. 2007; 56(1):27-78. PMC: 2134972. DOI: 10.1016/j.brainresrev.2007.05.004. View

Prediger R, Rojas-Mayorquin A, Aguiar Jr A, Chevarin C, Mongeau R, Hamon M . Mice with genetic deletion of the heparin-binding growth factor midkine exhibit early preclinical features of Parkinson's disease. J Neural Transm (Vienna). 2011; 118(8):1215-25. DOI: 10.1007/s00702-010-0568-3. View

Garcia-Perez D, Saez-Belmonte F, Laorden M, Nunez C, Milanes M . Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function. Br J Pharmacol. 2012; 168(8):1889-901. PMC: 3623059. DOI: 10.1111/bph.12083. View

Gramage E, Rossi L, Granado N, Moratalla R, Herradon G . Genetic inactivation of pleiotrophin triggers amphetamine-induced cell loss in the substantia nigra and enhances amphetamine neurotoxicity in the striatum. Neuroscience. 2010; 170(1):308-16. DOI: 10.1016/j.neuroscience.2010.06.078. View

10.

Jung C, Hida H, Nakahira K, Ikenaka K, Kim H, Nishino H . Pleiotrophin mRNA is highly expressed in neural stem (progenitor) cells of mouse ventral mesencephalon and the product promotes production of dopaminergic neurons from embryonic stem cell-derived nestin-positive cells. FASEB J. 2004; 18(11):1237-9. DOI: 10.1096/fj.03-0927fje. View

11.

Iseki K, Hagino S, Mori T, Zhang Y, Yokoya S, Takaki H . Increased syndecan expression by pleiotrophin and FGF receptor-expressing astrocytes in injured brain tissue. Glia. 2002; 39(1):1-9. DOI: 10.1002/glia.10078. View

12.

Lorenzetto E, Moratti E, Vezzalini M, Harroch S, Sorio C, Buffelli M . Distribution of different isoforms of receptor protein tyrosine phosphatase γ (Ptprg-RPTP γ) in adult mouse brain: upregulation during neuroinflammation. Brain Struct Funct. 2013; 219(3):875-90. DOI: 10.1007/s00429-013-0541-7. View

13.

Narita M, Miyatake M, Shibasaki M, Tsuda M, Koizumi S, Narita M . Long-lasting change in brain dynamics induced by methamphetamine: enhancement of protein kinase C-dependent astrocytic response and behavioral sensitization. J Neurochem. 2005; 93(6):1383-92. DOI: 10.1111/j.1471-4159.2005.03097.x. View

14.

Rock R, Hu S, Sheng W, Peterson P . Morphine stimulates CCL2 production by human neurons. J Neuroinflammation. 2006; 3:32. PMC: 1712222. DOI: 10.1186/1742-2094-3-32. View

15.

Hawes J, Brunzell D, Narasimhaiah R, Langel U, Wynick D, Picciotto M . Galanin protects against behavioral and neurochemical correlates of opiate reward. Neuropsychopharmacology. 2007; 33(8):1864-73. PMC: 2504505. DOI: 10.1038/sj.npp.1301579. View

16.

Gramage E, Martin Y, Ramanah P, Perez-Garcia C, Herradon G . Midkine regulates amphetamine-induced astrocytosis in striatum but has no effects on amphetamine-induced striatal dopaminergic denervation and addictive effects: functional differences between pleiotrophin and midkine. Neuroscience. 2011; 190:307-17. DOI: 10.1016/j.neuroscience.2011.06.014. View

17.

Svendsen C . The amazing astrocyte. Nature. 2002; 417(6884):29-32. DOI: 10.1038/417029a. View

18.

Gramage E, Putelli A, Polanco M, Gonzalez-Martin C, Ezquerra L, Alguacil L . The neurotrophic factor pleiotrophin modulates amphetamine-seeking behaviour and amphetamine-induced neurotoxic effects: evidence from pleiotrophin knockout mice. Addict Biol. 2010; 15(4):403-12. DOI: 10.1111/j.1369-1600.2009.00202.x. View

19.

Houshyar H, Manalo S, Dallman M . Time-dependent alterations in mRNA expression of brain neuropeptides regulating energy balance and hypothalamo-pituitary-adrenal activity after withdrawal from intermittent morphine treatment. J Neurosci. 2004; 24(42):9414-24. PMC: 6730111. DOI: 10.1523/JNEUROSCI.1641-04.2004. View

20.

Hayashi N, Oohira A, Miyata S . Synaptic localization of receptor-type protein tyrosine phosphatase zeta/beta in the cerebral and hippocampal neurons of adult rats. Brain Res. 2005; 1050(1-2):163-9. DOI: 10.1016/j.brainres.2005.05.047. View